Macquarie Group Ltd. lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 4.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,105,374 shares of the company’s stock after purchasing an additional 445,399 shares during the quarter. Macquarie Group Ltd. owned about 3.21% of Cardinal Health worth $676,253,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Bronfman E.L. Rothschild L.P. increased its stake in Cardinal Health by 31.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after acquiring an additional 382 shares during the last quarter. Advisory Services Network LLC increased its stake in Cardinal Health by 18.4% in the second quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock valued at $136,000 after acquiring an additional 270 shares during the last quarter. JFS Wealth Advisors LLC increased its stake in Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after acquiring an additional 244 shares during the last quarter. Dupont Capital Management Corp bought a new position in Cardinal Health in the second quarter valued at $164,000. Finally, First Personal Financial Services increased its stake in Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after acquiring an additional 1,238 shares during the last quarter. 88.64% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts recently commented on the company. Argus cut Cardinal Health from a “buy” rating to a “hold” rating in a research note on Wednesday. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating in a research note on Wednesday, November 8th. Jefferies Group LLC reduced their target price on Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a research note on Tuesday, November 7th. Mizuho set a $70.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Tuesday, October 24th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $74.81.

Cardinal Health, Inc. (CAH) traded up $0.59 during trading on Friday, hitting $57.42. 4,960,000 shares of the stock were exchanged, compared to its average volume of 2,364,550. The company has a current ratio of 1.06, a quick ratio of 0.52 and a debt-to-equity ratio of 1.35. Cardinal Health, Inc. has a one year low of $55.69 and a one year high of $84.88. The stock has a market capitalization of $18,100.00, a price-to-earnings ratio of 10.78, a P/E/G ratio of 1.64 and a beta of 0.88.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.09. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The business had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. During the same period last year, the business posted $1.24 earnings per share. Cardinal Health’s quarterly revenue was up 1.9% compared to the same quarter last year. sell-side analysts anticipate that Cardinal Health, Inc. will post 4.97 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be issued a $0.4624 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.85 annualized dividend and a yield of 3.22%. Cardinal Health’s dividend payout ratio (DPR) is presently 53.94%.

TRADEMARK VIOLATION NOTICE: “Cardinal Health, Inc. (CAH) Shares Bought by Macquarie Group Ltd.” was published by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/11/17/cardinal-health-inc-cah-shares-bought-by-macquarie-group-ltd.html.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.